Skip to main content
Arlette (Harper) Uihlein, MD, Pathology, Pittsburgh, PA

Arlette Harper (Harper) Uihlein MD FCAP FASCP

Cytopathology, Anatomic Pathology, Clinical Pathology


Physician

Join to View Full Profile
  • 91 43rd StHelomics CorpPittsburgh, PA 15201

  • Phone+1 800-547-6165

Dr. Uihlein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Allegheny Health Network Medical Education Consortium (AGH)
    Allegheny Health Network Medical Education Consortium (AGH)Residency, Pathology-Anatomic and Clinical, 2005 - 2010
  • Allegheny Health Network Medical Education Consortium (AGH)
    Allegheny Health Network Medical Education Consortium (AGH)Fellowship, Cytopathology, 2008 - 2009
  • TriHealth (Bethesda North Hospital)
    TriHealth (Bethesda North Hospital)Residency, Family Medicine, 1990 - 1991
  • University of Toledo
    University of ToledoResidency, Family Medicine, 1988 - 1990
  • The University of Toledo College of Medicine
    The University of Toledo College of MedicineClass of 1988

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1999 - 2026
  • OH State Medical License
    OH State Medical License 1990 - 2025
  • Pathology - Anatomic/Pathology - Clinical
    American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • Cytopathology
    American Board of Pathology Cytopathology

Publications & Presentations

PubMed

Press Mentions

  • Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Helomics Continues Progress Toward AI-Driven Predictive Model of Ovarian Cancer
    Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Helomics Continues Progress Toward AI-Driven Predictive Model of Ovarian CancerApril 9th, 2020
  • Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to Be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to Be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingMay 29th, 2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: